Brand dynamics
Group Real-Time Dynamics And Cutting-Edge Information In The Field Of One Health
Boosting the innovative development of the Guangdong-Hong Kong-Macao Greater Bay Area, Health Spring's subsidiary wins two major awards
Published Time：
2019-11-09
On November 8, 2019, the "Sixth Shenzhen Top 100 Autonomous Innovation Small and Medium-sized Enterprises and Top Ten Entrepreneurial Talents Award Ceremony" was grandly held at the OCT InterContinental Hotel. The ceremony was guided by the Shenzhen Municipal Science and Technology Innovation Commission, the Shenzhen Municipal Bureau of Small and Medium-sized Enterprise Services, and the China Association of Small and Medium-sized Enterprises, and jointly organized by the Municipal Small and Medium-sized Enterprise Development Promotion Association and the Shenzhen Special Zone Daily. Vice Mayor Wang Lixin attended the award ceremony and delivered a wonderful speech. Joincare Pharmaceutical Group Industry Co., Ltd. (hereinafter referred to as "Health Yuan Pharmaceutical Group"), its subsidiary Shenzhen Haibin Pharmaceutical Co., Ltd. (hereinafter referred to as "Haibin Pharmaceutical"), successfully entered the list of "Shenzhen Top 100 Autonomous Innovation Small and Medium-sized Enterprises" through the strict review of the expert panel, based on its excellent autonomous innovation capabilities and good business management performance. Mr. Lin Nanqi, General Manager of Shenzhen Haibin Pharmaceutical Co., Ltd., was awarded the title of "Shenzhen Top Ten Entrepreneurial Talents for Small and Medium-sized Enterprises". It was a double celebration.
Vice Mayor Wang delivered an important speech at the meeting, hoping that the vast number of small and medium-sized enterprises in the city would take Shenzhen quality and Shenzhen standards as benchmarks, and take practical actions to improve quality, create brands, establish credibility, and expand markets; strive to be practitioners of innovation-driven development, continuously improve their independent innovation capabilities, and enhance the internal driving force and core competitiveness of enterprises; strive to be pioneers in industrial transformation and upgrading, actively implement the "Made in China 2025" and "Internet Plus" action plans, seize opportunities, and promote enterprise transformation and development and cross-border integration with greater efforts.
It is understood that the "Shenzhen Top 100 Autonomous Innovation Small and Medium-sized Enterprises" selection activity is guided by the Municipal Science and Technology Innovation Commission, the Municipal Small and Medium-sized Enterprise Service Bureau, and the China Association of Small and Medium-sized Enterprises, and jointly organized by the Municipal Small and Medium-sized Enterprise Development Promotion Association and the Shenzhen Special Zone Daily. This selection activity has been held since 2006, biennially, and this year is the sixth session. It has become the most influential brand activity in our city. This year's selection activity attracted 3,000 companies to participate, most of which have core technologies, a large number of patents, and various intellectual property rights. Among them, the average number of patents owned by the top 100 candidate companies exceeds 40. The winning companies were selected from numerous applicants through a rigorous selection process and are excellent representatives of the millions of small and medium-sized enterprises in the city. For more than ten years, this award has played an important role in encouraging the independent innovation spirit of Shenzhen's small and medium-sized entrepreneurs and promoting the city's excellent small and medium-sized enterprises.
Shenzhen Haibin Pharmaceutical Co., Ltd.'s winning of two important awards is the best affirmation of the company's independent R&D capabilities, intellectual property protection capabilities, and future market development potential, and also marks a new stage for its parent company, Health Yuan Pharmaceutical Group, in leading innovative management. It is reported that the 100 winning companies all have outstanding achievements in independent innovation and cover various fields. Haibin Pharmaceutical has adhered to independent innovation for many years, constantly innovating. With the care and support of the government and the help and supervision of industry peers, its independent innovation capabilities have improved year by year, and its innovative achievements are also extremely impressive. The title of "Shenzhen Top Ten Entrepreneurial Talents" is an affirmation of General Manager Lin Nanqi's personal leadership and Haibin Pharmaceutical's innovative achievements. With the support and assistance of leaders at all levels, under the wise leadership of General Manager Lin Nanqi, and with the joint efforts of all employees, Haibin Pharmaceutical's future will surely be even more brilliant.
Mr. Lin Nanqi stated that he will continue to lead the company's employees to respond to the strategic adjustment of independent innovation, continuously improve the company's independent innovation organizational structure, strengthen learning, focus on core technology research and development, strengthen the transformation of scientific research results, and promote the innovative development of the Guangdong-Hong Kong-Macao Greater Bay Area while consolidating and enhancing its own core competitive advantages.
Quick Navigation
+86 755-33268688 | Service Hotline
Official WeChat Official Account
Copyright © 2025 Joincare Pharmaceutical Group Industry Co., Ltd. ALL Rights Reserve.